GAMMA Investing
LYEL icon

GAMMA Investing’s Lyell Immunopharma LYEL Stock Holding History

GAMMA Investing’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.46K Buy
353
+318
+909% +$4.23K ﹤0.01% 3787
2026
Q2 		$492 Hold
35
– – ﹤0.01% 3986
2026
Q1 		$702 Hold
35
– – ﹤0.01% 3899
2025
Q4 		$1.08K Hold
35
– – ﹤0.01% 3768
2025
Q3 		$568 Hold
35
– – ﹤0.01% 3697
2025
Q2 		$309 Buy
+35
New +$319 ﹤0.01% 3690

Other funds holding LYEL

Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing's LYEL Position: Q3 2026 in Review

GAMMA Investing increased its Lyell Immunopharma (LYEL) stake by 909% in Q3 2026, buying an estimated $4.23K and bringing the position to 353 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

GAMMA Investing first reported a position in LYEL in Q2 2025 and has held it in 6 quarters since. 5 funds tracked by Wall St. Rank hold LYEL as of Q3 2026.

  • GAMMA Investing held 353 shares of Lyell Immunopharma worth $3.46K as of Q3 2026.
  • GAMMA Investing bought 318 Lyell Immunopharma shares in Q3 2026, an estimated $4.23K.
  • Lyell Immunopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3787 holding.
  • GAMMA Investing first reported a position in Lyell Immunopharma in Q2 2025 and has held it in 6 quarters since.
  • 5 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.